Where is Valkit.ai located?

Valkit.ai is headquartered in Indianapolis, United States.

Where does Valkit.ai rank among its competitors?

Valkit.ai ranks 175th amongst 625 active competitors, of which 69 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was mPharma, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of Valkit.ai?

Valkit.ai's top competitors include Novotech, Dedalus and Concert AI. Among them, mPharma secured the most recent funding round in December, 2025.

Valkit.ai - 2026 Company Profile & Competitors

Company Details

Developer of an AI-augmented digital validation platform for life sciences. The platform provides tools for document management, traceability, project oversight, and security. It offers features such as automated version control, electronic signatures, and requirement mapping. The platform facilitates integrations with development operations tools.

Key Metrics

Founded Year

2023

Location

Indianapolis, United States

Stage

Unfunded

Ranked

175^th among 625 active competitors

Similar Companies

Novotech & 199 more

View Valkit.ai's full profile

Valkit.ai has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Valkit.ai include Novotech, Dedalus and Concert AI. Here is the list of Top 10 competitors of Valkit.ai, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novotech 2002, Sydney (Australia), Acquired	Provider of clinical research services across all trial phases and therapeutic areas	$255M	GIC, Sequoia Capital & 5 others	68/100
2nd	Dedalus 1982, Milano (Italy), Acquired	Provider of advanced software solutions that enhance healthcare interoperability	$26.9M	ADIA, Tamburi Investment Partners & 8 others	64/100
3rd	Concert AI 2018, Boston (United States), Series C	Provider of AI and real-world data solutions for life sciences	$300M	Sixth Street, Declaration Partners & 4 others	64/100
4th	Bioptimus 2024, Paris (France), Series A	Developer of AI foundation model to transform biological research	$76M	Sofinnova Partners, Bpifrance & 15 others	63/100
5th	Dotmatics 2005, Bishop s Stortford (United Kingdom), Acquired	AI powered scientific data management and workflow automation solutions	$11.3M	Scottish Equity Partners, Insight Partners ... & 4 others	61/100
6th	Greenlight Guru 2013, Indianapolis (United States), Series A	Developer of quality management system software for the medical device industry	$121M	JMI Management, Elevate Ventures	61/100
7th	mPharma 2013, Accra (Ghana), Series D	Provider of pharmacy management services and software for stock management for patients and pharmacies	$95.3M	Novastar Ventures, Alchemist Accelerator ... & 33 others	60/100
8th	MasterControl 1994, Salt Lake City (United States), Late Stage	Developer of software for quality, manufacturing, and asset management solutions	$150M	Sixth Street, Sixth Street Growth	59/100
9th	MedMe Health 2019, Toronto (Canada), Seed	Cloud based pharmacy management software for professionals	$3.69M	M12, MaRS IAF & 7 others	59/100
10th	Health Gorilla 2014, Coral Gables (United States), Series C	Provider of healthcare information network platform to access patient data	$80M	IA Capital Group, SignalFire & 14 others	58/100
175th	Valkit.ai 2023, Indianapolis (United States), Unfunded	Developer of an AI-augmented digital validation platform for life sciences	-	-	29/100